Navigation Links
BiOptix announces expansion of Innovators Program into Europe
Date:9/26/2013

BOULDER, Colo. and BASEL, Switzerland, Sept. 26, 2013 /PRNewswire/ -- BiOptix formally announced the European expansion of the BiOptix Innovators Program at MipTec & BioValley Life Sciences Week, being held in Basel, Switzerland from September 24 – 26, 2013.  During the event, the company is launching the BiOptix Innovators Program into Europe, with an emphasis on partnering with key research institutions, pharmaceutical companies and biotechnology/drug discovery firms.  The BiOptix Innovators Program is a unique and innovative product evaluation platform that allows customers to try BiOptix SPR technology independently in their lab, on their timeframe and with complete customer and technical support during the evaluation. 

"This is the third year that BiOptix has participated in MipTec and the BioValley Life Sciences Week in Basel, and the 2013-2014 season brings an opportunity for us to expand our presence in this market with this distinctive program," noted Ken Wilczek, Vice President, Sales & Marketing for BiOptix.  "The life science research corridor in Europe is growing at a substantial rate, and we are excited to be a part of this expansion."  Additional details about the BiOptix Innovators Program can be found at: http://www.bioptix.com/products/innovators-program

Surface Plasmon Resonance is an advanced and highly sensitive optical technology that measures refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.

About BiOptix
BiOptix Diagnostics is a privately held firm based in Boulder, Colorado, with leading investments from Boulder Ventures, Remeditex and Rusnano.  BiOptix has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR – Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction—with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements. Additional information about BiOptix and our products can be found at:  www.bioptix.com


'/>"/>
SOURCE BiOptix
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BiOptix announces low cost Surface Plasmon Resonance Services for Colorado-based researchers
2. BiOptix to highlight new carbonic anhydrase data at IBCs Biopharmaceutical Development & Production Week
3. BiOptix announces expansion of Innovators Program at Molecular Med TRI-CON 2013
4. BiOptix Announces Fall 2012 Tradeshow and Symposia Schedule
5. Ampio Pharmaceuticals, Inc. Announces $25 Million Financing
6. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
7. Pro-Dex, Inc. Announces Fiscal 2013 Fourth Quarter And Full-Year Results
8. OralHygenix Announces Freedom Oral Care System (FOCS) for People with Physical and Mental Disabilities
9. STEMSOFT Announces Release of New Cord Banking Software Solution
10. PipelineRx Announces Expansion into Ten New States with Telepharmacy Services
11. Genarts 18th Annual Film Festival Announces Collaboration With The Partnership At Drugfree.org For #endmedicineabuse Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... 22, 2017  As the latest Obamacare repeal effort ... Cassidy (R-LA) and Lindsey Graham (R-SC) ... medical device industry is in an odd place.  The ... 2.3% excise tax on medical device sales passed along ... covered patients, increased visits and hospital customers with the ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board ... Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will ... Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of President ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and ... Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD ... that can be easily incorporated into liquid products, while reducing costs to end users. ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Lori R. ... a member of ElderCounsel, a national organization of elder law and special needs planning ... laws and rules. It also provides a forum to network with elder law attorneys ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
Breaking Medicine News(10 mins):